文献速递腹部技术与安全MR

用超极化13C丙酮酸MRI与质谱表征肝细胞癌的代谢异质性

Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized 13C Pyruvate MRI and Mass Spectrometry.
PubMed 文献 · Radiol Imaging Cancer · 2024-01-01

研究在43只雌性Fischer大鼠中植入N1S1或McA-RH7777肝细胞癌肿瘤,用9.4T超极化13C MRI测乳酸/丙酮酸比值,并用质谱测瘤内代谢物、Ki67量化增殖。N1S1肿瘤乳酸/丙酮酸比值高于正常肝(0.564±0.194 vs 0.311±0.057,P<.001),McA-RH7777无差异;两种亚型基线及转化至高增殖状态时糖酵解依赖不同。

要点

  • N1S1肿瘤超极化13C MRI乳酸/丙酮酸比值高于正常肝(P<.001),McA-RH7777与正常肝无显著差异(P=.44)。
  • 刺激后N1S1肿瘤乳酸/丙酮酸比值净增加(0.269±0.148 vs 0.027±0.08,P=.009),McA-RH7777无显著变化(P=.13)。
  • 肝细胞癌代谢异质性应在使用超极化13C MRI诊断和追踪时加以考虑。

核心结论

  • 两种肝细胞癌亚型在基线和向高增殖状态转化时表现出不同的糖酵解依赖性,这种代谢异质性应在使用超极化13C MRI诊断和追踪时加以考虑。

研究设计与样本

  • 研究论文;43只雌性成年Fischer大鼠植入N1S1或McA-RH7777肝细胞癌肿瘤,在9.4T下行超极化13C MRI测在体乳酸/丙酮酸比值,离体质谱测瘤内代谢物,Ki67标记量化增殖;肿瘤先与三个正常肝对照比较,再与经离靶肝热消融处理的刺激变体比较;所有比较用Mann-Whitney检验。

关键影像表现/征象

  • 超极化13C丙酮酸MRI显示N1S1肿瘤乳酸/丙酮酸比值高于正常肝(均值[SD] 0.564±0.194 vs 0.311±0.057;P<.001;n=9)。
  • McA-RH7777肿瘤与正常肝的乳酸/丙酮酸比值无显著差异(P=.44;n=8)。
  • 质谱证实N1S1肿瘤糖酵解通路增加而McA-RH7777肿瘤降低,戊糖磷酸通路仅在McA-RH7777肿瘤降低。

诊断标准与关键数值

  • 超极化13C MRI测量的乳酸/丙酮酸比值(LPR)用于区分肿瘤与正常肝:N1S1肿瘤均值0.564±0.194 vs 正常肝0.311±0.057(P<.001,n=9)。
  • McA-RH7777肿瘤与正常肝的LPR比较无显著差异(P=.44,n=8)。
  • 刺激N1S1肿瘤六只 vs 未刺激六只,LPR净增加0.269±0.148 vs 0.027±0.08(P=.009);McA-RH7777刺激八只 vs 未刺激六只无显著差异(P=.13)。

临床应用与阅片要点

  • 原文结论指出肝细胞癌的代谢异质性应在使用超极化13C MRI诊断和追踪时加以考虑。
  • 原文未据此给出具体阅片或报告推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To characterize the metabolomic profiles of two hepatocellular carcinoma (HCC) rat models, track evolution of these profiles to a stimulated tumor state, and assess their effect on lactate flux with hyperpolarized (HP) carbon 13 (13C) MRI. Materials and Methods Forty-three female adult Fischer rats were implanted with N1S1 or McA-RH7777 HCC tumors. In vivo lactate-to-pyruvate ratio (LPR) was measured with HP 13C MRI at 9.4 T. Ex vivo mass spectrometry was used to measure intratumoral metabolites, and Ki67 labeling was used to quantify proliferation. Tumors were first compared with three normal liver controls. The tumors were then compared with stimulated variants via off-target hepatic thermal ablation treatment. All comparisons were made using the Mann-Whitney test. Results HP 13C pyruvate MRI showed greater LPR in N1S1 tumors compared with normal liver (mean [SD], 0.564 ± 0.194 vs 0.311 ± 0.057; P < .001 [n = 9]), but not for McA-RH7777 (P = .44 [n = 8]). Mass spectrometry confirmed that the glycolysis pathway was increased in N1S1 tumors and decreased in McA-RH7777 tumors. The pentose phosphate pathway was also decreased only in McA-RH7777 tumors. Increased proliferation in stimulated N1S1 tumors corresponded to a net increase in LPR (six stimulated vs six nonstimulated, 0.269 ± 0.148 vs 0.027 ± 0.08; P = .009), but not in McA-RH7777 (eight stimulated vs six nonstimulated, P = .13), despite increased proliferation and metastases. Mass spectrometry demonstrated relatively increased lactate production with stimulation in N1S1 tumors only. Conclusion Two HCC subtypes showed divergent glycolytic dependency at baseline and during transformation to a high proliferation state. This metabolic heterogeneity in HCC should be considered with use of HP 13C MRI for diagnosis and tracking. Keywords: Molecular Imaging-Probe Development, Liver, Abdomen/GI, Oncology, Hepatocellular Carcinoma © RSNA, 2024 See also commentary by Ohliger in this issue.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Dou Q, Grant AK, Coutinto de Souza P, et al. Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized 13C Pyruvate MRI and Mass Spectrometry. Radiol Imaging Cancer. 2024. PMID: 38426887. doi:10.1148/rycan.230056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。